Search Results 1181-1190 of 16198 for chemoprevention
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...
2024. Digital Health Awards, Gold, Health System, Consumer Audience · 2022. eHealthCare Leadership Awards, Gold, Best Overall Internet Site, Healthcare System ...
Rochester, Minn. This phase II trial studies how well erismodegib and lenalidomide after stem cell transplant works in treating patients with multiple myeloma.
The research of Mark D. Tyson II, M.D., M.P.H., at Mayo Clinic mainly focuses on learning more about and treating urologic cancers, with an emphasis on ...
Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...
The purpose of the study is to alleviate the occurrence of chemotherapy-induced nausea (CIN) and to improve chemotherapy treatment outcomes.
The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...
Cancer recurrences are diagnosed just like any other cancer. Your health care provider might suspect a cancer recurrence based on certain tests, or you might ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.